Chronic obstructive pulmonary disease. Are the times changing?
Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases and a major cause of morbidity and mortality in Spain. Currently, COPD is considered a treatable disease with an inflammatory origin that is frequently associated with other diseases. The prevalence of comorbidity is...
Gespeichert in:
| Veröffentlicht in: | Revista clínica espanõla (English edition) 2013-04, Vol.213 (3), p.152-157 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 157 |
|---|---|
| container_issue | 3 |
| container_start_page | 152 |
| container_title | Revista clínica espanõla (English edition) |
| container_volume | 213 |
| creator | Almagro, P Sangil, A Custardoy, J San Román Terán, C Martín Escudero, J C Díez-Manglano, J |
| description | Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases and a major cause of morbidity and mortality in Spain. Currently, COPD is considered a treatable disease with an inflammatory origin that is frequently associated with other diseases. The prevalence of comorbidity is clearly increased in patients with COPD, irrespective of other confounding variables such as smoking. Current treatments have been proven to slow the loss of lung function, decrease the number of exacerbations and improve health-related quality of life and survival. New advances regarding the classics and more recent phenotypes such as patients with frequent exacerbations or COPD with associated comorbidity should allow for more individualized treatment while advances in genetic research and inflammatory mechanisms of the disease will help us to increase our knowledge of the disease and the development of new treatments. |
| doi_str_mv | 10.1016/j.rce.2012.01.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1353476119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1353476119</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-f4daa60a4680766bd96e25d47ee52ac191286f17415097fb6d401afcd673eb9b3</originalsourceid><addsrcrecordid>eNo1j0tLxDAUhYMgzjDOD3AjXbppzU3zaDbKUHzBgBtdlzS5ncnQl0kr-O8tOC4OZ3E-DnyE3ADNgIK8P2XBYsYosIxCRqm4IGvGBE-LQvEV2cZ4onRZQQtJr8iKMU651mxNHspjGHpvk6GOU5jt5L8xGee2G3oTfhLnI5qIWbILmEzHJb7DmNij6Q--Pzxek8vGtBG3596Qz-enj_I13b-_vJW7fToChyltuDNGUsNlQZWUtdMSmXBcIQpmLGhghWxAcRBUq6aWjlMwjXVS5VjrOt-Qu7_fMQxfM8ap6ny02Lamx2GOFeQi50oC6AW9PaNz3aGrxuC7RaX6d85_AcVkV38</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1353476119</pqid></control><display><type>article</type><title>Chronic obstructive pulmonary disease. Are the times changing?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Almagro, P ; Sangil, A ; Custardoy, J ; San Román Terán, C ; Martín Escudero, J C ; Díez-Manglano, J</creator><creatorcontrib>Almagro, P ; Sangil, A ; Custardoy, J ; San Román Terán, C ; Martín Escudero, J C ; Díez-Manglano, J ; Grupo de EPOC de la Sociedad Española de Medicina Interna</creatorcontrib><description>Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases and a major cause of morbidity and mortality in Spain. Currently, COPD is considered a treatable disease with an inflammatory origin that is frequently associated with other diseases. The prevalence of comorbidity is clearly increased in patients with COPD, irrespective of other confounding variables such as smoking. Current treatments have been proven to slow the loss of lung function, decrease the number of exacerbations and improve health-related quality of life and survival. New advances regarding the classics and more recent phenotypes such as patients with frequent exacerbations or COPD with associated comorbidity should allow for more individualized treatment while advances in genetic research and inflammatory mechanisms of the disease will help us to increase our knowledge of the disease and the development of new treatments.</description><identifier>EISSN: 2254-8874</identifier><identifier>DOI: 10.1016/j.rce.2012.01.005</identifier><identifier>PMID: 22404992</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Aged ; Disease Progression ; Humans ; Phenotype ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - diagnosis ; Pulmonary Disease, Chronic Obstructive - therapy</subject><ispartof>Revista clínica espanõla (English edition), 2013-04, Vol.213 (3), p.152-157</ispartof><rights>Copyright © 2011 Elsevier España, S.L. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22404992$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Almagro, P</creatorcontrib><creatorcontrib>Sangil, A</creatorcontrib><creatorcontrib>Custardoy, J</creatorcontrib><creatorcontrib>San Román Terán, C</creatorcontrib><creatorcontrib>Martín Escudero, J C</creatorcontrib><creatorcontrib>Díez-Manglano, J</creatorcontrib><creatorcontrib>Grupo de EPOC de la Sociedad Española de Medicina Interna</creatorcontrib><title>Chronic obstructive pulmonary disease. Are the times changing?</title><title>Revista clínica espanõla (English edition)</title><addtitle>Rev Clin Esp (Barc)</addtitle><description>Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases and a major cause of morbidity and mortality in Spain. Currently, COPD is considered a treatable disease with an inflammatory origin that is frequently associated with other diseases. The prevalence of comorbidity is clearly increased in patients with COPD, irrespective of other confounding variables such as smoking. Current treatments have been proven to slow the loss of lung function, decrease the number of exacerbations and improve health-related quality of life and survival. New advances regarding the classics and more recent phenotypes such as patients with frequent exacerbations or COPD with associated comorbidity should allow for more individualized treatment while advances in genetic research and inflammatory mechanisms of the disease will help us to increase our knowledge of the disease and the development of new treatments.</description><subject>Aged</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Phenotype</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - diagnosis</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><issn>2254-8874</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tLxDAUhYMgzjDOD3AjXbppzU3zaDbKUHzBgBtdlzS5ncnQl0kr-O8tOC4OZ3E-DnyE3ADNgIK8P2XBYsYosIxCRqm4IGvGBE-LQvEV2cZ4onRZQQtJr8iKMU651mxNHspjGHpvk6GOU5jt5L8xGee2G3oTfhLnI5qIWbILmEzHJb7DmNij6Q--Pzxek8vGtBG3596Qz-enj_I13b-_vJW7fToChyltuDNGUsNlQZWUtdMSmXBcIQpmLGhghWxAcRBUq6aWjlMwjXVS5VjrOt-Qu7_fMQxfM8ap6ny02Lamx2GOFeQi50oC6AW9PaNz3aGrxuC7RaX6d85_AcVkV38</recordid><startdate>201304</startdate><enddate>201304</enddate><creator>Almagro, P</creator><creator>Sangil, A</creator><creator>Custardoy, J</creator><creator>San Román Terán, C</creator><creator>Martín Escudero, J C</creator><creator>Díez-Manglano, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201304</creationdate><title>Chronic obstructive pulmonary disease. Are the times changing?</title><author>Almagro, P ; Sangil, A ; Custardoy, J ; San Román Terán, C ; Martín Escudero, J C ; Díez-Manglano, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-f4daa60a4680766bd96e25d47ee52ac191286f17415097fb6d401afcd673eb9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Phenotype</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - diagnosis</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Almagro, P</creatorcontrib><creatorcontrib>Sangil, A</creatorcontrib><creatorcontrib>Custardoy, J</creatorcontrib><creatorcontrib>San Román Terán, C</creatorcontrib><creatorcontrib>Martín Escudero, J C</creatorcontrib><creatorcontrib>Díez-Manglano, J</creatorcontrib><creatorcontrib>Grupo de EPOC de la Sociedad Española de Medicina Interna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista clínica espanõla (English edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Almagro, P</au><au>Sangil, A</au><au>Custardoy, J</au><au>San Román Terán, C</au><au>Martín Escudero, J C</au><au>Díez-Manglano, J</au><aucorp>Grupo de EPOC de la Sociedad Española de Medicina Interna</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic obstructive pulmonary disease. Are the times changing?</atitle><jtitle>Revista clínica espanõla (English edition)</jtitle><addtitle>Rev Clin Esp (Barc)</addtitle><date>2013-04</date><risdate>2013</risdate><volume>213</volume><issue>3</issue><spage>152</spage><epage>157</epage><pages>152-157</pages><eissn>2254-8874</eissn><abstract>Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases and a major cause of morbidity and mortality in Spain. Currently, COPD is considered a treatable disease with an inflammatory origin that is frequently associated with other diseases. The prevalence of comorbidity is clearly increased in patients with COPD, irrespective of other confounding variables such as smoking. Current treatments have been proven to slow the loss of lung function, decrease the number of exacerbations and improve health-related quality of life and survival. New advances regarding the classics and more recent phenotypes such as patients with frequent exacerbations or COPD with associated comorbidity should allow for more individualized treatment while advances in genetic research and inflammatory mechanisms of the disease will help us to increase our knowledge of the disease and the development of new treatments.</abstract><cop>Spain</cop><pmid>22404992</pmid><doi>10.1016/j.rce.2012.01.005</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2254-8874 |
| ispartof | Revista clínica espanõla (English edition), 2013-04, Vol.213 (3), p.152-157 |
| issn | 2254-8874 |
| language | eng ; spa |
| recordid | cdi_proquest_miscellaneous_1353476119 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Aged Disease Progression Humans Phenotype Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - therapy |
| title | Chronic obstructive pulmonary disease. Are the times changing? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A31%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20obstructive%20pulmonary%20disease.%20Are%20the%20times%20changing?&rft.jtitle=Revista%20cl%C3%ADnica%20espan%C3%B5la%20(English%20edition)&rft.au=Almagro,%20P&rft.aucorp=Grupo%20de%20EPOC%20de%20la%20Sociedad%20Espa%C3%B1ola%20de%20Medicina%20Interna&rft.date=2013-04&rft.volume=213&rft.issue=3&rft.spage=152&rft.epage=157&rft.pages=152-157&rft.eissn=2254-8874&rft_id=info:doi/10.1016/j.rce.2012.01.005&rft_dat=%3Cproquest_pubme%3E1353476119%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1353476119&rft_id=info:pmid/22404992&rfr_iscdi=true |